[(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate

C38H65N2O4+ — CID 173395632

IUPAC[(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate
SMILESCCCC(=O)OC1C([N+]2(CC)CCCCCC2)C[C@H]2[C@@H]3CCC4CC(OC(C)=O)C(N5CCCCC5)C[C@]4(C)[C@@H]3CC[C@]12C
InChIInChI=1S/C38H65N2O4/c1-6-15-35(42)44-36-33(40(7-2)22-13-8-9-14-23-40)25-31-29-17-16-28-24-34(43-27(3)41)32(39-20-11-10-12-21-39)26-38(28,5)30(29)18-19-37(31,36)4/h28-34,36H,6-26H2,1-5H3/q+1/t28?,29-,30-,31+,32?,33?,34?,36?,37+,38+/m1/s1
InChIKeyJZMMJAKQTUZNTD-CEOZCKQOSA-N
MW613.95 g/mol
LogP7.53
Rot. Bonds7

About [(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate

[(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate (PubChem CID 173395632) has the molecular formula C38H65N2O4+ and a molecular weight of 613.95 g/mol. Its IUPAC name is [(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate.

Molecular Properties

Compound Name[(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate
PubChem CID173395632
Molecular FormulaC38H65N2O4+
Molecular Weight613.95 g/mol
Exact Mass613.49
IUPAC Name[(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate
SMILESCCCC(=O)OC1C([N+]2(CC)CCCCCC2)C[C@H]2[C@@H]3CCC4CC(OC(C)=O)C(N5CCCCC5)C[C@]4(C)[C@@H]3CC[C@]12C
InChIInChI=1S/C38H65N2O4/c1-6-15-35(42)44-36-33(40(7-2)22-13-8-9-14-23-40)25-31-29-17-16-28-24-34(43-27(3)41)32(39-20-11-10-12-21-39)26-38(28,5)30(29)18-19-37(31,36)4/h28-34,36H,6-26H2,1-5H3/q+1/t28?,29-,30-,31+,32?,33?,34?,36?,37+,38+/m1/s1
InChIKeyJZMMJAKQTUZNTD-CEOZCKQOSA-N
XLogP7.53
TPSA55.84 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms44
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500613.95
LogP ≤ 57.53
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}

Analyze [(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate?
The IUPAC name of [(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate (CID 173395632) is [(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate.
What is the SMILES notation for [(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate?
The canonical SMILES for [(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate is CCCC(=O)OC1C([N+]2(CC)CCCCCC2)C[C@H]2[C@@H]3CCC4CC(OC(C)=O)C(N5CCCCC5)C[C@]4(C)[C@@H]3CC[C@]12C.
What is the InChIKey of [(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate?
The InChIKey is JZMMJAKQTUZNTD-CEOZCKQOSA-N. The full InChI is InChI=1S/C38H65N2O4/c1-6-15-35(42)44-36-33(40(7-2)22-13-8-9-14-23-40)25-31-29-17-16-28-24-34(43-27(3)41)32(39-20-11-10-12-21-39)26-38(28,5)30(29)18-19-37(31,36)4/h28-34,36H,6-26H2,1-5H3/q+1/t28?,29-,30-,31+,32?,33?,34?,36?,37+,38+/m1/s1.
What are the key properties of [(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate?
[(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate has a molecular weight of 613.95 g/mol, XLogP of 7.53, 7 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(8R,9R,10S,13S,14S)-3-acetyloxy-16-(1-ethylazepan-1-ium-1-yl)-10,13-dimethyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate is sourced from PubChem (CID 173395632), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).